IceCure Medical Ltd (ICCM)
USD 1.23
(-0.81%)
USD 1.23
(-0.81%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 16.87 Million USD | -7.19% |
| 2022 | 18.18 Million USD | 52.56% |
| 2021 | 11.91 Million USD | 69.79% |
| 2020 | 7.01 Million ILS | 35.39% |
| 2019 | 5.18 Million ILS | 43.27% |
| 2018 | 3.61 Million ILS | 27.44% |
| 2017 | 2.83 Million ILS | -14.59% |
| 2016 | 3.32 Million ILS | -12.63% |
| 2015 | 3.8 Million ILS | -14.9% |
| 2014 | 4.47 Million ILS | 22.43% |
| 2013 | 3.65 Million ILS | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.88 Million USD | -7.39% |
| 2024 Q2 | 3.7 Million USD | -3.24% |
| 2023 Q3 | 4.1 Million USD | -9.19% |
| 2023 FY | 16.87 Million USD | -7.19% |
| 2023 Q1 | 4.27 Million USD | -2.64% |
| 2023 Q2 | 4.51 Million USD | 5.56% |
| 2023 Q4 | 4.19 Million USD | 2.29% |
| 2022 Q2 | 4.66 Million USD | -3.99% |
| 2022 FY | 18.18 Million USD | 52.56% |
| 2022 Q4 | 4.39 Million USD | 2.95% |
| 2022 Q1 | 4.85 Million USD | 28.85% |
| 2022 Q3 | 4.26 Million USD | -8.53% |
| 2021 Q4 | 3.77 Million USD | 17.51% |
| 2021 Q2 | 2.8 Million USD | 31.66% |
| 2021 Q1 | 2.13 Million USD | 5.18% |
| 2021 FY | 11.91 Million USD | 69.79% |
| 2021 Q3 | 3.2 Million USD | 14.32% |
| 2020 FY | 7.01 Million ILS | 35.39% |
| 2020 Q4 | 2.02 Million USD | 13.68% |
| 2020 Q2 | 1.38 Million USD | 0.0% |
| 2020 Q1 | 1.38 Million USD | 0.42% |
| 2020 Q3 | 1.78 Million USD | 28.46% |
| 2019 Q3 | 1.37 Million USD | 10.09% |
| 2019 Q4 | 1.38 Million USD | 0.66% |
| 2019 FY | 5.18 Million ILS | 43.27% |
| 2019 Q2 | 1.24 Million USD | 1.79% |
| 2019 Q1 | 1.22 Million USD | -8.32% |
| 2018 Q1 | 908.46 Thousand USD | 16.26% |
| 2018 FY | 3.61 Million ILS | 27.44% |
| 2018 Q4 | 1.33 Million USD | 42.1% |
| 2018 Q3 | 940.5 Thousand USD | 8.47% |
| 2018 Q2 | 867.06 Thousand USD | -4.56% |
| 2017 Q3 | 705.17 Thousand USD | -5.32% |
| 2017 FY | 2.83 Million ILS | -14.59% |
| 2017 Q4 | 781.41 Thousand USD | 10.81% |
| 2017 Q1 | 717.3 Thousand USD | 4.25% |
| 2017 Q2 | 744.77 Thousand USD | 3.83% |
| 2016 Q4 | 688.03 Thousand USD | 8.74% |
| 2016 Q1 | 1.19 Million USD | 58.7% |
| 2016 Q2 | 851.7 Thousand USD | -28.65% |
| 2016 Q3 | 632.71 Thousand USD | -25.71% |
| 2016 FY | 3.32 Million ILS | -12.63% |
| 2015 Q3 | 1.01 Million USD | 4.75% |
| 2015 Q4 | 752.23 Thousand USD | -25.59% |
| 2015 Q2 | 965.16 Thousand USD | -11.15% |
| 2015 Q1 | 1.08 Million USD | -36.61% |
| 2015 FY | 3.8 Million ILS | -14.9% |
| 2014 Q3 | 1.24 Million USD | -8.78% |
| 2014 FY | 4.47 Million ILS | 22.43% |
| 2014 Q1 | 1.11 Million USD | -10.5% |
| 2014 Q2 | 1.36 Million USD | 22.27% |
| 2014 Q4 | 1.71 Million USD | 37.31% |
| 2013 Q4 | 1.25 Million USD | 48.84% |
| 2013 Q1 | 956.58 Thousand USD | -22.07% |
| 2013 FY | 3.65 Million ILS | 0.0% |
| 2013 Q2 | 816.56 Thousand USD | -14.64% |
| 2013 Q3 | 839.92 Thousand USD | 2.86% |
| 2012 Q4 | 1.22 Million USD | 15.21% |
| 2012 Q3 | 1.06 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -50.356% |
| Cerus Corporation | 143.15 Million USD | 88.211% |
| OrthoPediatrics Corp. | 137.01 Million USD | 87.683% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -48.545% |
| Talis Biomedical Corporation | 67.18 Million USD | 74.882% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 32.35% |
| Inogen, Inc. | 236.08 Million USD | 92.852% |
| Spectral AI, Inc. | 20.86 Million USD | 19.114% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 69.863% |
| CVRx, Inc. | 76.14 Million USD | 77.836% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -378.345% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -35.127% |
| Orthofix Medical Inc. | 667.42 Million USD | 97.471% |
| Venus Concept Inc. | 80.47 Million USD | 79.03% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 70.172% |
| Bioventus Inc. | 409.91 Million USD | 95.883% |
| BrainsWay Ltd. | 28.01 Million USD | 39.767% |
| Envoy Medical, Inc. | 17.89 Million USD | 5.71% |
| electroCore, Inc. | 32.03 Million USD | 47.314% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 60.228% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 4.293% |
| MaxCyte, Inc. | 84.84 Million USD | 80.11% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -35.968% |
| Nexalin Technology, Inc. | 5.78 Million USD | -191.904% |
| PAVmed Inc | 64.82 Million USD | 73.968% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 66.96% |
| RxSight, Inc. | 103.85 Million USD | 83.75% |
| Sight Sciences, Inc. | 126.44 Million USD | 86.654% |
| SI-BONE, Inc. | 156.35 Million USD | 89.206% |
| TELA Bio, Inc. | 84.18 Million USD | 79.954% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 75.911% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 91.702% |
| LivaNova PLC | 843.54 Million USD | 97.999% |
| 908 Devices Inc. | 68.08 Million USD | 75.212% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 96.51% |
| Nemaura Medical Inc. | 7.13 Million USD | -136.398% |
| NeuroPace, Inc. | 75.29 Million USD | 77.587% |
| LENSAR, Inc. | 33.33 Million USD | 49.376% |
| Apyx Medical Corporation | 51.01 Million USD | 66.921% |
| Cutera, Inc. | 197.72 Million USD | 91.465% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 31.899% |
| BioSig Technologies, Inc. | 28.53 Million USD | 40.848% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 91.186% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 53.2% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 97.982% |
| Axonics, Inc. | 270.2 Million USD | 93.754% |
| Outset Medical, Inc. | 198.77 Million USD | 91.51% |
| IRIDEX Corporation | 31.81 Million USD | 46.954% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 90.636% |
| IRadimed Corporation | 30.12 Million USD | 43.976% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -97.797% |
| INVO Bioscience, Inc. | 7.85 Million USD | -114.891% |
| Telesis Bio, Inc. | 63.48 Million USD | 73.419% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 82.859% |
| Varex Imaging Corporation | 224.8 Million USD | 92.493% |
| Quipt Home Medical Corp. | 148.66 Million USD | 88.648% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -43.956% |
| Pulmonx Corporation | 112.68 Million USD | 85.024% |
| Dynatronics Corporation | 9.9 Million USD | -70.327% |
| Modular Medical, Inc. | 17.52 Million USD | 3.725% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 16.402% |
| Semler Scientific, Inc. | 38.94 Million USD | 56.666% |
| InMode Ltd. | 215.68 Million USD | 92.175% |
| Bruker Corporation | 1.07 Billion USD | 98.432% |
| Cytosorbents Corporation | 48.33 Million USD | 65.087% |
| DexCom, Inc. | 1.69 Billion USD | 99.002% |
| Align Technology, Inc. | 2.07 Billion USD | 99.187% |
| Viveve Medical, Inc. | 22.17 Million USD | 23.889% |
| ZimVie Inc. | 275.12 Million USD | 93.866% |
| Movano Inc. | 29.69 Million USD | 43.159% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 87.706% |
| Nexalin Technology, Inc. | 5.78 Million USD | -191.904% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -378.345% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 97.192% |
| Profound Medical Corp. | 33.6 Million USD | 49.779% |
| Insulet Corporation | 939.9 Million USD | 98.204% |
| enVVeno Medical Corporation | 25.23 Million USD | 33.133% |
| Surmodics, Inc. | 98.69 Million USD | 82.901% |
| iCAD, Inc. | 22.22 Million USD | 24.067% |
| Nuwellis, Inc. | 22.61 Million USD | 25.37% |
| Biotricity, Inc. | 17.18 Million USD | 1.796% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 96.215% |
| Aethlon Medical, Inc. | 12.27 Million USD | -37.455% |
| InspireMD, Inc. | 22.95 Million USD | 26.466% |
| PAVmed Inc. | 64.82 Million USD | 73.968% |
| BIOLASE, Inc. | 34.66 Million USD | 51.311% |
| Beyond Air, Inc. | 61.7 Million USD | 72.648% |
| FONAR Corporation | 28.6 Million USD | 41.003% |
| AxoGen, Inc. | 149.33 Million USD | 88.699% |
| Vivani Medical, Inc. | 26.96 Million USD | 37.415% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 90.47% |
| Inari Medical, Inc. | 448.59 Million USD | 96.238% |
| UFP Technologies, Inc. | 58.08 Million USD | 70.948% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -242.479% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -167.098% |
| Tenon Medical, Inc. | 16.96 Million USD | 0.542% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -128.27% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 61.735% |
| AdaptHealth Corp. | 1.07 Billion USD | 98.434% |
| Sintx Technologies, Inc. | 15.2 Million USD | -11.019% |
| NanoVibronix, Inc. | 4.97 Million USD | -239.353% |
| Quanterix Corporation | 118.1 Million USD | 85.71% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -43.956% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -16.854% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 95.702% |
| TransMedics Group, Inc. | 182.82 Million USD | 90.769% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 39.868% |
| NeuroMetrix, Inc. | 11.09 Million USD | -52.051% |
| Hyperfine, Inc. | 52.87 Million USD | 68.081% |
| Establishment Labs Holdings Inc. | 172 Million USD | 90.189% |
| Biomerica, Inc. | 6.97 Million USD | -141.846% |
| Bone Biologics Corporation | 9.42 Million USD | -78.993% |
| AVITA Medical, Inc. | 80.77 Million USD | 79.108% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -63.666% |
| Silk Road Medical, Inc | 186.35 Million USD | 90.944% |